| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC3386 |
| Trial ID | NCT05795595 |
| Disease | Malignant Pleural Mesothelioma | Pancreatic Adenocarcinoma | Exocervical Carcinoma | Clear Cell Renal Cell Carcinoma | Esophageal Carcinoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CTX131 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors |
| Year | 2023 |
| Country | United States |
| Company sponsor | CRISPR Therapeutics AG |
| Other ID(s) | CRSP-ONC-005 |
| Cohort 1 | |||||||||
|
|||||||||